LMO2 and leukemia: In a subset of pediatric (3.7%) and adult (5.5%) T-ALL the LMO2 gene contains intronic indels that result in de novo binding sites for the leukemia-associated transcription factors MYB, ETS1 or RUNX1 and thus dysregulated LMO2 expression (80).